• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中对青少年进行普遍常规抑郁症筛查的成本效益分析

Cost-Effectiveness of Universal Routine Depression Screening for Adolescents in Primary Care.

作者信息

Doan Tran T, Hutton David W, Wright Davene R, Prosser Lisa A

机构信息

Department of Health Systems, Management, and Policy, Colorado School of Public Health, Aurora.

Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor.

出版信息

JAMA Health Forum. 2025 May 2;6(5):e250711. doi: 10.1001/jamahealthforum.2025.0711.

DOI:10.1001/jamahealthforum.2025.0711
PMID:40314942
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12048853/
Abstract

IMPORTANCE

Approximately one-fifth of adolescents in the US experience a major depressive episode each year. Universal depression screening for adolescents is recommended as part of routine pediatric primary care, but its cost-effectiveness is unclear.

OBJECTIVE

To evaluate the cost-effectiveness of universal routine depression screening in adolescent primary care compared with usual care.

DESIGN, SETTING, AND PARTICIPANTS: This economic evaluation used a decision-analytic model with an embedded state-transition submodel and annual transitions. A hypothetical population of 1000 adolescents and young adults from ages 12 to 22 years, including 12 demographic groups of disaggregated combinations of sex (female and male) and race or ethnicity (American Indian or Alaska Native; Asian, Native Hawaiian, or Pacific Islander; Black or African American; Hispanic, Latino, or Spanish; White; and multiracial or other race or ethnicity) was simulated in pediatric primary care settings.

EXPOSURES

Universal depression screening of varying frequencies, including annual, biennial, and single-time screening at age 12 years, compared with usual care, defined as 20% annual screening rate.

MAIN OUTCOMES AND MEASURES

Costs, health effects as measured by quality-adjusted life-years (QALYs) and depression-free days, and incremental cost-effectiveness ratios (ICERs) from the health care sector and limited societal perspectives.

RESULTS

A universal annual screening policy had an ICER of $66 822 per QALY or $84 per depression-free day gained compared with single-time screening from the limited societal perspective, including caregiver time costs. Universal single-time screening had an ICER of $44 483 per QALY and $62 per depression-free day gained compared with usual care. Targeted universal depression screening was more cost-effective for female individuals and those who identified as Hispanic, Latina, or Spanish, multiracial, or other race or ethnicity. Results were sensitive to treatment recovery rates, depression health state utility scores, treatment costs involving psychotherapy, suicide-related hospitalization costs, and initial depression prevalence at age 12 years. In approximately 99.8% of probabilistic simulations, universal annual screening had an ICER less than $150 000 per QALY threshold.

CONCLUSIONS AND RELEVANCE

The study results suggest that universal annual depression screening for adolescents in primary care is cost-effective compared with a $100 000 per QALY willingness-to-pay threshold. Universal annual screening may be more cost-effective if health systems invest in efforts to enhance family access to telemedicine behavioral health, decrease treatment costs, or improve treatment effectiveness. Future analyses could examine whether additional potentially associated demographic factors, such as gender orientation, sexual identity, rurality, or comorbidities, affect cost-effectiveness outcomes.

摘要

重要性

美国每年约五分之一的青少年经历过一次重度抑郁发作。建议将青少年普遍抑郁症筛查作为儿科初级保健常规项目的一部分,但筛查的成本效益尚不清楚。

目的

评估青少年初级保健中普遍常规抑郁症筛查与常规护理相比的成本效益。

设计、设置和参与者:这项经济评估使用了一个决策分析模型,该模型包含一个状态转换子模型和年度转换。在儿科初级保健环境中模拟了1000名年龄在12至22岁之间的青少年和年轻人的假设人群,包括12个人口统计学组,这些组是按性别(女性和男性)以及种族或族裔(美国印第安人或阿拉斯加原住民;亚裔、夏威夷原住民或太平洋岛民;黑人或非裔美国人;西班牙裔、拉丁裔或西班牙人;白人;以及多种族或其他种族或族裔)的不同组合划分的。

暴露因素

不同频率的普遍抑郁症筛查,包括每年、每两年以及12岁时单次筛查,与常规护理进行比较,常规护理定义为每年20%的筛查率。

主要结局和衡量指标

成本、以质量调整生命年(QALYs)和无抑郁天数衡量的健康效果,以及从医疗保健部门和有限社会视角得出的增量成本效益比(ICERs)。

结果

从有限社会视角(包括照顾者时间成本)来看,与单次筛查相比,普遍每年筛查政策每获得一个QALY的ICER为66822美元,或每增加一个无抑郁天数的ICER为84美元。与常规护理相比,普遍单次筛查每获得一个QALY的ICER为44483美元,每增加一个无抑郁天数的ICER为62美元。有针对性的普遍抑郁症筛查对女性个体以及那些认定为西班牙裔、拉丁裔或西班牙人、多种族或其他种族或族裔的人更具成本效益。结果对治疗康复率、抑郁健康状态效用评分、涉及心理治疗的治疗成本、与自杀相关的住院成本以及12岁时的初始抑郁患病率敏感。在大约99.8%的概率模拟中,普遍每年筛查的ICER低于每QALY阈值150000美元。

结论与意义

研究结果表明,与每QALY支付意愿阈值100000美元相比,在初级保健中对青少年进行普遍每年抑郁症筛查具有成本效益。如果卫生系统投资努力加强家庭获得远程医疗行为健康服务的机会、降低治疗成本或提高治疗效果,普遍每年筛查可能更具成本效益。未来的分析可以研究是否有其他潜在相关的人口统计学因素,如性取向、性身份、农村地区或合并症,会影响成本效益结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/12048853/f0c4521215d0/jamahealthforum-e250711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/12048853/55e402ab625f/jamahealthforum-e250711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/12048853/f0c4521215d0/jamahealthforum-e250711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/12048853/55e402ab625f/jamahealthforum-e250711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/12048853/f0c4521215d0/jamahealthforum-e250711-g002.jpg

相似文献

1
Cost-Effectiveness of Universal Routine Depression Screening for Adolescents in Primary Care.基层医疗中对青少年进行普遍常规抑郁症筛查的成本效益分析
JAMA Health Forum. 2025 May 2;6(5):e250711. doi: 10.1001/jamahealthforum.2025.0711.
2
The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings: A Randomized Clinical Trial.协作式护理治疗青少年抑郁症的成本和成本效益:一项随机临床试验。
JAMA Pediatr. 2016 Nov 1;170(11):1048-1054. doi: 10.1001/jamapediatrics.2016.1721.
3
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.多基因药物基因组学检测,包括用于指导抗抑郁药物选择的决策支持工具:一项卫生技术评估。
Ont Health Technol Assess Ser. 2021 Aug 12;21(13):1-214. eCollection 2021.
4
Cost-Effectiveness of Computer-Assisted Cognitive Behavioral Therapy for Depression Among Adults in Primary Care.计算机辅助认知行为疗法治疗初级保健中成年人抑郁症的成本效益。
JAMA Netw Open. 2024 Nov 4;7(11):e2444599. doi: 10.1001/jamanetworkopen.2024.44599.
5
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA.估计美国青少年中性别和种族或族裔组合的主要抑郁症建模的转移概率。
Appl Health Econ Health Policy. 2024 May;22(3):375-390. doi: 10.1007/s40258-024-00872-6. Epub 2024 Jan 22.
6
Balancing Efficiency and Equity in Population-Wide CKD Screening.在全人群慢性肾脏病筛查中平衡效率与公平性
JAMA Netw Open. 2025 Apr 1;8(4):e254740. doi: 10.1001/jamanetworkopen.2025.4740.
7
Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.互联网提供的针对重度抑郁症和焦虑症的认知行为疗法:一项卫生技术评估。
Ont Health Technol Assess Ser. 2019 Feb 19;19(6):1-199. eCollection 2019.
8
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.宫颈癌及相关宫颈疾病的预防:致癌性人乳头瘤病毒(HPV)疫苗接种的成本效益综述
J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217.
9
The cost-effectiveness of screening for oral cancer in primary care.基层医疗中口腔癌筛查的成本效益
Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. doi: 10.3310/hta10140.
10
Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.阿基仑赛和Tisagenlecleucel 作为二线或更后线治疗复发或难治弥漫性大 B 细胞淋巴瘤的成本效益分析。
JAMA Netw Open. 2022 Dec 1;5(12):e2245956. doi: 10.1001/jamanetworkopen.2022.45956.

引用本文的文献

1
Errors in Results and Table 1.结果及表1中的错误。
JAMA Health Forum. 2025 Jun 7;6(6):e252603. doi: 10.1001/jamahealthforum.2025.2603.

本文引用的文献

1
The Risk Of Perpetuating Health Disparities Through Cost-Effectiveness Analyses.通过成本效益分析延续健康差异的风险。
Health Aff (Millwood). 2024 Aug;43(8):1165-1171. doi: 10.1377/hlthaff.2023.01583.
2
Screening for depression in children and adolescents in primary care or non-mental health settings: a systematic review update.基层医疗保健或非心理健康环境中儿童和青少年的抑郁筛查:系统评价更新。
Syst Rev. 2024 Jan 31;13(1):48. doi: 10.1186/s13643-023-02447-3.
3
Examining how well economic evaluations capture the value of mental health.
审视经济评估在多大程度上体现了心理健康的价值。
Lancet Psychiatry. 2024 Mar;11(3):221-230. doi: 10.1016/S2215-0366(23)00436-4. Epub 2024 Jan 25.
4
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA.估计美国青少年中性别和种族或族裔组合的主要抑郁症建模的转移概率。
Appl Health Econ Health Policy. 2024 May;22(3):375-390. doi: 10.1007/s40258-024-00872-6. Epub 2024 Jan 22.
5
Clinical predictors of suicidal ideation, suicide attempts and suicide death in depressive disorder: a systematic review and meta-analysis.抑郁障碍中自杀意念、自杀未遂和自杀死亡的临床预测因素:系统评价和荟萃分析。
Eur Arch Psychiatry Clin Neurosci. 2024 Oct;274(7):1543-1563. doi: 10.1007/s00406-023-01716-5. Epub 2023 Nov 28.
6
Estimates of Major Depressive Disorder and Treatment Among Adolescents by Race and Ethnicity.青少年种族和民族的重度抑郁症和治疗的估计。
JAMA Pediatr. 2023 Nov 1;177(11):1215-1223. doi: 10.1001/jamapediatrics.2023.3996.
7
Preferences and experiences of pediatricians on implementing national guidelines on universal routine screening of adolescents for major depressive disorder: A qualitative study.儿科医生对实施全国青少年普遍常规筛查主要抑郁障碍的国家指南的偏好和经验:一项定性研究。
Compr Psychiatry. 2023 Nov;127:152412. doi: 10.1016/j.comppsych.2023.152412. Epub 2023 Aug 18.
8
Trends in Pediatric Primary Care Visits During the COVID-19 Pandemic: Opportunity to Address Adolescent Behavioral Health Through Telemedicine.COVID-19 大流行期间儿科初级保健就诊趋势:通过远程医疗解决青少年行为健康问题的机会。
Fam Med. 2023 Oct;55(9):620-624. doi: 10.22454/FamMed.2023.755040. Epub 2023 Jul 24.
9
Suicidal Thoughts and Behaviors Among High School Students - Youth Risk Behavior Survey, United States, 2021.高中生的自杀意念和行为 - 2021 年美国青年风险行为调查。
MMWR Suppl. 2023 Apr 28;72(1):45-54. doi: 10.15585/mmwr.su7201a6.
10
Modelling in economic evaluation of mental health prevention: current status and quality of studies.心理健康预防的经济评价中的建模:研究现状和质量。
BMC Health Serv Res. 2022 Jul 13;22(1):906. doi: 10.1186/s12913-022-08206-9.